Humacyte Company

Humacyte is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at a commercial scale to improve the lives of patients and transform the practice of medicine.

Investors

Connections from

Last Funding Type: Reverse Merger
Funding Status: Private investment in public equity(PIPE)
Headquarters: United States
Founded Date: 01.01.2004
Last Funding Date: 17.02.2021
Total Funding: $400 000 000
Technology: Specific disorder-related
Employee Number: 101-250
Estimated Revenue: $10-50 Mn
Investors Number: 9
Industry: Longevity
N/A
Register and Claim Ownership